Tergus Pharma has announced plans to build a state-of-the-art commercial manufacturing facility in the Raleigh-Durham, NC area and will begin construction in July 2019. The new 100,000 square foot facility will have Clinical Trial Material (Phases I thru III) Supplies and commercial manufacturing capabilities and expand current capacity by over 400%. Tergus plans to open the new facility in early 2020, enabling the company to act as a CDMO by providing comprehensive services from development through manufacturing. This expansion comes as Targus announces a partnership with Great Point Partners which will provide the requisite funding. Learn More